The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary clinical pharmacokinetics and dose-response to support a phase II dose selection for CX-2009: A masked probody drug conjugate to CD166.
 
Mark Stroh
Employment - CytomX Therapeutics
Stock and Other Ownership Interests - CytomX Therapeutics
Travel, Accommodations, Expenses - CytomX Therapeutics
 
Rachel Li
Employment - CytomX Therapeutics
Stock and Other Ownership Interests - CytomX Therapeutics
Honoraria - CytomX Therapeutics
Travel, Accommodations, Expenses - CytomX Therapeutics
 
Hong Lu
No Relationships to Disclose
 
Russ Wada
Employment - Certara Inc
 
Jennifer Hope Richardson
Employment - CytomX Therapeutics
Stock and Other Ownership Interests - CytomX Therapeutics
Research Funding - CytomX Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Patents (Inst)
Travel, Accommodations, Expenses - CytomX Therapeutics
 
John W. Frye
Employment - Aduro Biotech; CytomX Therapeutics
Stock and Other Ownership Interests - CytomX Therapeutics
Travel, Accommodations, Expenses - Aduro Biotech; CytomX Therapeutics
 
Amy C. Peterson
Employment - BeiGene; CytomX Therapeutics
Leadership - BeiGene; CytomX Therapeutics
Stock and Other Ownership Interests - Agios; BeiGene; CytomX Therapeutics; Deciphera; Nektar
Consulting or Advisory Role - Gerson Lehrman Group
Patents, Royalties, Other Intellectual Property - Patent for development of a novel diagnostic assay in patients with triple negative breast cancer for the use of enzalutamide
Travel, Accommodations, Expenses - BeiGene; CytomX Therapeutics